228253-41-6

Upstream product

• 136721-64-7 N-(2-bromoacetyl)-S-(triphenylmethyl)-2-aminoethanethiol 
• 152863-83-7 N-[2-[(triphenylmethyl)thio]ethyl]-2-[[2-[(triphenylmethyl)thio]ethyl]amino]acetamide 
• 1095-85-8 2-amino tritylthio ethane 
• 76-84-6 triphenylmethyl alcohol 
• 915380-02-8 4-{(2-tritylsulfanyl-ethyl)-[(2-tritylsulfanyl-ethylcarbamoyl)-methyl]-amino}-butyric acid methyl ester 
• 848087-34-3 4-{(2-tritylsulfanyl-ethyl)-[(2-tritylsulfanyl-ethylcarbamoyl)-methyl]-amino}-butyric acid ethyl ester 

Downstream Products

• 848087-36-5 N²-[4-[(3,3-diphosphonopropyl)amino]-4-oxobutyl]-N¹,N²-bis[2-(tritylthio)ethyl]glycinamide 
• 848087-35-4 [1-phosphono-3-[4-[[2-(tritylthio)ethyl][[2-(tritylthio)ethylcarbamoyl]methyl]amino]butyrylamino]propyl]phosphonic acid tetraethyl ester 

Relevant academic research and scientific papers

Synthesis and biological evaluation of technetium-99m-labeled deoxyglucose derivatives as imaging agents for tumor

Three deoxyglucose (DG) derivatives, S-DG, MAG3-DG and MAMA-BA-DG, were synthesized and labeled successfully with high labeling yields and high radio-chemical purities. Biodistribution in tumor-bearing mice demonstrated that these three new su

Design of a radiopharmaceutical for the palliation of painful bone metastases: Rhenium-186-labeled bisphosphonate derivative

To develop a radiopharmaceutical for the palliation of painful bone metastases based on the concept of bifunctional radiopharmaceuticals, we designed a bisphosphonate derivative attached to a stable 186Re- monoaminemonoamidedithiol (MAMA) chela